NCT05939999

Brief Summary

Evaluate the effect of the use of elastic tape in chest wall and abdomen in the physical capacity, psychosocial distress levels, quality of life and anxiety, and depression symptoms of individuals with moderate to very severe chronic obstructive pulmonary disease (COPD) undergoing pulmonary rehabilitation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 11, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

October 26, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

December 9, 2024

Status Verified

December 1, 2024

Enrollment Period

1.4 years

First QC Date

June 29, 2023

Last Update Submit

December 4, 2024

Conditions

Keywords

rehabilitationexercise capacityhealth-related quality of lifeelastic tape

Outcome Measures

Primary Outcomes (1)

  • Functional Exercise Capacity: The total time reached in the Endurance Shuttle Walking Test (ESWT)

    The patients will be instructed to walk in a 10-meter corridor limited by cones (with a distance of 9 meters between them), and the speed will be determined by a sound signal issued by cell phone, in this case, the speed will be determined using 85% of the maximum speed reached in the Incremental Shuttle Walking Test (ISWT) and will be constant throughout the test.

    Change from baseline at 8 weeks of intervention.

Secondary Outcomes (3)

  • Clinical Control: COPD Assessment Test™ (CAT) is a specific questionnaire for COPD that assesses the impact of the symptoms of the disease

    Change from baseline at 8 weeks of intervention.

  • Symptoms of Anxiety and Depression: Hospital Anxiety and Depression Scale (HADS): The questionnaire was developed to identify symptoms of anxiety and depressive mood.

    Change from baseline at 8 weeks of intervention.

  • Health-related Quality of Life: was assessed by using the Chronic Respiratory Questionnaire (CRQ)

    Change from baseline at 8 weeks of intervention.

Study Arms (2)

Elastic tape (ET)

EXPERIMENTAL

The group that will participate in the 8 weeks pulmonary rehabilitation protocol using the elastic tape.

Other: Experimental: Elastic tape (ET)

Sham (SH)

SHAM COMPARATOR

The group that will participate in the pulmonary rehabilitation protocol using micropore tape.

Other: Sham Comparator: Sham (SH)

Interventions

The elastic tape will be allocated in the chest wall and abdomen of individuals and will be used during the 8 weeks of rehabilitation protocol.

Elastic tape (ET)

The micropore tape will be allocated in the chest wall and abdomen of individuals and will be used during the 8 weeks of rehabilitation protocol.

Sham (SH)

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Moderate to very severe COPD diagnosis according to Global Iniciative for Chronic Obstructive Lung Disease (GOLD) 2020
  • Clinical stability (i.e., no exacerbations for at least 30 days)
  • Male
  • Non-obese (BMI ≤29.9 kg/m2)
  • No musculoskeletal limitation
  • Not included in a pulmonary rehabilitation program in the last 6 months.
  • Do not perform home oxygen therapy

You may not qualify if:

  • Present osteoarticular, cognitive, neurological, and/or cardiological dysfunctions that prevent physical training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Hospital of São Paulo University medical school (HCFMUSP)

São Paulo, São Paulo, 05360-160, Brazil

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Celso RF Carvalho

    University of Sao Paulo General Hospital

    STUDY DIRECTOR

Central Study Contacts

Celso RF Carvalho, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Evaluations will be conducted blindly, that is, by an evaluator who will not be directly involved in the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2023

First Posted

July 11, 2023

Study Start

October 26, 2023

Primary Completion

April 1, 2025

Study Completion

May 1, 2025

Last Updated

December 9, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations